Atlas Trials

Acute Myeloid Leukaemia

31 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Acute Myeloid Leukaemia

RecordFirmDate
Anti-NKG2A Monoclonal Antibody for AML or MDS Patients Undergoing Haploidentical Transplantation (NCT06892223)Istituto Clinico Humanitas2021-12-03
Phase I/II Trial of S64315 Plus Azacitidine in Acute Myeloid Leukaemia (NCT04629443)Institut de Recherches Internationales Servier2021-02-17
A Trial of Treatments to Assess the Effects on Outcome of Adults With AML and MDS Undergoing Allogeneic SCT (NCT04217278)University of Birmingham2020-01-27
Phase I Dose Escalation Study of Intravenously Administered S64315 in Combination With Orally Administered Venetoclax in Patients With Acute Myeloid Leukaemia. (NCT03672695)Institut de Recherches Internationales Servier2018-11-28
Safety, Tolerability, Pharmacokinetics, and Efficacy of AZD2811 Nanoparticles as Monotherapy or in Combination in Acute Myeloid Leukemia Participants. (NCT03217838)AstraZeneca2017-07-31
International Randomised Phase III Clinical Trial in Children With Acute Myeloid Leukaemia (NCT02724163)University of Birmingham2016-04-01
Trial to Test the Effects of Adding 1 of 2 New Treatment Agents to Commonly Used Chemotherapy Combinations (NCT02272478)Cardiff University2014-10-30
Chemotherapy Followed by Infusion of Partially HLA Matched Unrelated Donor Cells for Patients With AML Who Are Ineligible for Stem Cell Transplantation (NCT02189824)University of Sydney2014-08-01
Transfusion Dependency at Diagnosis and Transfusion Intensity During Initial Chemotherapy Are Associated With Poorer Outcomes in Adult Acute Myeloid Leukaemia (NCT02844257)Hospices Civils de Lyon2014-01-01
Trial of Haploidentical Stem Cell Transplantation for Haematological Cancers (NCT01597219)University College, London2013-03-01
WT1 TCR Gene Therapy for Leukaemia: A Phase I/II Safety and Toxicity Study (NCT01621724)Cell Medica Ltd2012-04-01
A Trial to Establish the Feasibility of Combining Either the Tyrosine Kinase Inhibitor AC220,CXCR4 Inhibitor Plerixafor or HSP90 Inhibitor Ganetespib With Chemotherapy in Older Patients With Acute Myeloid Leukaemia and High Risk Myelodysplastic Syndrome. (NCT01236144)Cardiff University2011-04-01
Clofarabine Pre-conditioning With Allogeneic Transplant for Acute Myeloid Leukaemia (AML) (NCT01422603)University Hospital Southampton NHS Foundation Trust2011-02-01
Safety Study of Anti LewisY Chimeric Antigen Receptor in Myeloma, Acute Myeloid Leukemia or Myelodysplastic Syndrome (NCT01716364)Peter MacCallum Cancer Centre, Australia2010-01-01
An Open Label, Single Centre Mass Balance C14 Study in Patients With Acute Myeloid Leukaemia (AML) (NCT01019161)AstraZeneca2009-11-01
Safety, Tolerability and PK of AZD1152 in Patients With Relapsed Acute Myeloid Leukaemia (AML) (NCT00530699)AstraZeneca2007-11-01
Comparison of the OSHO Protocol to a Standard Arm Protocol of the German AML Intergroup in Patients With AML>60a (NCT01497002)University of Leipzig2005-04-01
Treosulfan Based Conditioning Acute Myeloid Leukaemia (AML) (NCT01063660)medac GmbH2004-03-01
Comparison of the OSHO Protocol to a Standard Arm Protocol of the German AML Intergroup in Patients With AML<60a (NCT01414231)University of Leipzig2002-04-01

Track Acute Myeloid Leukaemia automatically

Every clearance here is in the API, with alerts when new ones post.